14.44USD-1.63%Mkt Cap: 192.13M USDP/E: —Last update: 2026-06-01
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and ser…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap192.13M USD
Enterprise Value178.05M USD
Revenue (TTM)116.26M USD
Gross Profit63.81M USD
Net Income (TTM)-10.88M USD
Revenue/Share8.218 USD
Last Price14.44 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees235
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)31.59
PEG3.63
EV/EBITDA-25.95
EV/Revenue1.53
P/S1.66
P/B1.45
EPS (TTM)-0.79
EPS (Forward)0.46
52W Range
7.87079% of range16.24
52W High16.24 USD
52W Low7.870 USD
Profitability
Gross Margin56.56%
Oper. Margin-18.53%
EBITDA Margin-5.90%
Profit Margin-9.64%
ROE-7.58%
ROA-5.72%
Growth
Revenue Growth13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF11.19M USD
CapEx (TTM)6.83M USD
FCF Margin5.47%
FCF Yield3.31%
Net Debt-15.28M USD
Net Debt/EBITDA2.23
Balance Sheet
Debt/Equity0.18
Current Ratio4.46
Quick Ratio3.19
Book Value/Sh10.03 USD
Cash/Share3.083 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)17.50 USD
Target Range17.00 USD – 18.00 USD
# Analysts2
Ownership
Shares Out.13.31M
Float11.30M
Insiders5.97%
Institutions94.73%
Short Interest
Short Ratio4.9d
Short % Float5.59%
Short % Out.4.25%
Shares Short565.57K
Short (prev mo.)644.57K
Technical
SMA 5014.81 (-2.5%)
SMA 20011.16 (+29.4%)
Beta0.16
S&P 52W Chg27.94%
Avg Vol (30d)97.30K
Avg Vol (10d)74.16K
Technical Indicators
RSI (14)48.4
MACD0.0321
MACD Signal0.0627
MACD Hist.-0.0306
BB Upper15.29 USD
BB Middle14.88 USD
BB Lower14.47 USD
BB Width5.45%
ATR (14)0.6561 USD
Vol Ratio (20d)0.40x